Literature DB >> 28780118

Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative.

Christine Guillard-Maure1, Varalakshmi Elango2, Steven Black3, Silvia Perez-Vilar4, Jose Luis Castro5, Pamela Bravo-Alcántara6, Helvert Felipe Molina-León7, Daniel Weibel8, Miriam Sturkenboom9, Patrick L F Zuber10.   

Abstract

Timely and effective evaluation of vaccine safety signals for newly developed vaccines introduced in low and middle- income countries (LMICs) is essential. The study tested the development of a global network of hospital-based sentinel sites for vaccine safety signal verification and hypothesis testing. Twenty-six sentinel sites in sixteen countries across all WHO regions participated, and 65% of the sites were from LMIC. We describe the process for the establishment and operationalization of such a network and the lessons learned in conducting a multi-country collaborative initiative. 24 out of the 26 sites successfully contributed data for the global analysis using standardised tools and procedures. Our study successfully confirmed the well-known risk estimates for the outcomes of interest. The main challenges faced by investigators were lack of adequate information in the medical records for case ascertainment and classification, and access to immunization data. The results suggest that sentinel hospitals intending to participate in vaccine safety studies strengthen their systems for discharge diagnosis coding, medical records and linkage to vaccination data. Our study confirms that a multi-country hospital-based network initiative for vaccine safety monitoring is feasible and demonstrates the validity and utility of large collaborative international studies to monitor the safety of new vaccines introduced in LMICs.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Adverse events following immunization (AEFI); Global Vaccine Safety Initiative (GVSI); Post-marketing surveillance; Vaccine safety

Mesh:

Substances:

Year:  2017        PMID: 28780118     DOI: 10.1016/j.vaccine.2017.07.085

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies.

Authors:  Jerome Ateudjieu; Beat Stoll; Anne Cecile Bisseck; Ayok M Tembei; Blaise Genton
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

Review 2.  Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions.

Authors:  Caitlin Dodd; Nick Andrews; Helen Petousis-Harris; Miriam Sturkenboom; Saad B Omer; Steven Black
Journal:  BMJ Glob Health       Date:  2021-05

3.  Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project.

Authors:  Apoorva Sharan; Shubhashri Jahagirdar; Anke L Stuurman; Varalakshmi Elango; Margarita Riera-Montes; Neeraj Kumar Kashyap; Narendra Kumar Arora; Mathews Mathai; Punam Mangtani; Hugo Devlieger; Steven Anderson; Barbee Whitaker; Hui-Lee Wong; Clare L Cutland; Christine Guillard Maure
Journal:  Vaccine X       Date:  2022-04-09

4.  Assessing the Safety of COVID-19 Vaccines: A Primer.

Authors:  Helen Petousis-Harris
Journal:  Drug Saf       Date:  2020-09-30       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.